Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

 

Natural Health Newsletter

Randall Neustaedter OMD

Monkeypox – Not Yet Wildfire, But Soon

Attack of the lowly prairie dog

Monkeypox is usually contracted in Africa by eating rodents or monkeys, or being bitten. The first episode of monkeypox in the US occurred in May, contracted from pet rodents. Cute prairie dogs, at $100 a pop, have been traded at swap meets and sold at pet stores. They are fuzzy and adorable. But these little Tribbles have also acquired some deadly traits in the form of an African virus apparently caught from a Gambian rat.

Twenty kindergarteners were exposed to an infected pet prairie dog at their school. Now those kids are quarantined. Several families in the Midwest have contracted the disease. Monkeypox has spread, along with the infected prairie dogs, to Illinois, Indiana, Michigan, Wisconsin, Ohio, and New Jersey. The count of suspected cases is nearing the hundred mark. One child in the US has encephalitis. No one has died. Yet.

Some prairie dogs have died. They could easily be discarded in the trash. The scenario of rats in the trash dump contracting the disease and spreading deadly monkeypox through the wild rodent population is juicy enough to warrant a Hollywood movie pitch. Dust off that faded copy of Dustin Hoffman’s movie, Outbreak, at your local video store.

Although monkeypox is usually contracted from infected animals, the disease will spread between people. In Africa, monkeypox infection usually stops after the first person-to-person transmission, but the disease was once tracked through four human transmissions among children. Officials expect monkeypox to spread between people in the US as well. Two health care workers now have monkeypox symptoms, and the boyfriend of one of the nurses has developed suspicious symptoms, which would represent a second-generation transmission. Not everyone with monkeypox disease has obvious symptoms. Like smallpox, this pox disease can cause inapparent infections, and those people could conceivably spread the disease.

Because the disease can spread between people, the federal government has issued guidelines for the use of smallpox vaccine to prevent this form of transmission even though the FDA has not approved the vaccine for this use. Health officials have evoked emergency powers protocols to make the vaccine available. Indiana is the first state to adopt these guidelines and make the smallpox vaccine available for this purpose.

Does the smallpox (vaccinia) vaccine work to prevent monkeypox?

Officials are claiming that the vaccine is 85 percent effective. That figure is based on one study done in the 1980s in Africa. That study evaluated 209 cases of monkeypox that occurred during a five-year period from 1980-1984 in the dense tropical rainforests of the Democratic Republic of Congo (at that time Zaire). These cases represented 125 separate episodes of disease occurrence. More than half of the cases did not spread to anyone else (only one case occurred in most episodes). The incidence of disease among vaccinated contacts of people with monkeypox was compared to the incidence in unvaccinated contacts. Both household contacts and people living in other residences were included. Over 1500 contacts of patients with the disease were identified. Only 12 cases of disease occurred in 1,099 vaccinated contacts (one percent) compared to 35 cases in 474 unvaccinated contacts (7.4 percent). The calculation (7.4-1.1 / 7.4) yields the 85 percent effectiveness conclusion. The assumption that smallpox vaccine works is based on this small sample of 47 cases, hardly a definitive answer. Many other factors, including the ability to identify and locate contacts in this environment could have altered the results.

Will monkeypox spread through a population?

That question has been evaluated in a few studies. In the study quoted above, 11 percent of household contacts contracted the disease. The majority of cases (78 percent) did not spread the disease at all in this partially vaccinated population. The longest recorded chain of human-to-human transmission of mankeypox lasted five generations, where the disease spread from one child who had eaten monkey meat with his family to four other children who had no contact with infected animals. The authors of this study constructed a mathematical model based on the transmission rate in that African setting. Based on an assumption that each individual with monkeypox would come into contact with ten other people while the individual was contagious, the authors concluded that 54 percent of cases are predicted to cause at least one subsequent case in an unvaccinated population. Theoretically, this could result in one additional case for every case of monkeypox, and the persistence of the disease in a population. However, the tactics of isolation, quarantine, and (perhaps) the vaccination of contacts would have the potential of stopping the disease’s spread. And monkeypox does tend to lose its infectous quality through transmissions in humans. The human is not considered a very good host for the disease, compared to rodents and other mammals. The spread of monkeypox from person to person is considerably less common than the spread of smallpox. Only 11 percent of unvaccinated household contacts of those with monkeypox acquired the disease compared to 40 to 97 percent of household contacts of people with smallpox (different strains of the virus having more or less virulence).

Media stories on monkeypox have repeatedly stated that vaccination within four days of exposure will prevent the disease. This figure has been estimated for smallpox prevention using the vaccinia vaccine and is erroneously attributed to monkeypox prevention. Several authorities have even questioned the veracity of this statement about smallpox prevention. In 1960, one researcher stated that smallpox vaccination given within four days of exposure still results in a 10-40 percent incidence of smallpox (Kempe, 1960).

What should you do?

If you live in an area where monkeypox has been identified, begin taking supplements that boost immune function.

Adults can take vitamin C (3-4 grams), vitamin A (20,000 IU), zinc (25 mg), and colostrum (2 tspns) every day.

Children can take vitamin C (500-1000 mg), vitamin A (1,000-5,000 IU), zinc (10-20 mg), and colostrum (1/2-1 tspn). The lower dose for infants and children up to three years old, the higher dose for children four and over.

I do not recommend that people get the smallpox vaccine unless a local clinic can supply vaccinia immune globulin (VIG) in the event of severe adverse reactions to the vaccination. For a more detailed discussion of the smallpox vaccine see the excerpt from my book, The Vaccine Guide, at:

http://cure-guide.com/Vaccine_Guide/Vaccine_Guide_excerpts/Smallpox_Vaccine/smallpox_vaccine.html

 

References

Fine PE, Jezek Z, Grab B, Dixon H. The transmission potential of monkeypox virus in human populations. Int J Epidemiol. 1988; Sep;17(3):643-50.

Jezek Z, et al. Four generations of probable person-to-person transmission of human monkeypox. Am Journal of Epidemiol 1986; 123(6):1004-1012.

Kempe CH. Studies of smallpox and complications of smallpox vaccine. Pediatrics 1960; 26:176-189.

 

Randall Neustaedter OMD, LAc
Classical Medicine Center
1779 Woodside Rd #201C
Redwood City, CA 94061
650 299-9170

View previous newsletter articles at
www.cure-guide.com

Author of The Vaccine Guide, North Atlantic Books

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.